Cited by 475Coronary Interventions and DiagnosticsCardiac Imaging and DiagnosticsCerebrovascular and Carotid Artery Diseases

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Intravascular Ultrasound-Derived Measures of Coronary Atherosclerotic Plaque Burden and Clinical Outcome

Open access

Nicholls, Stephen J., Hsu, Amy, Wolski, Kathy, Hu, Bo, Bayturan, Ozgur, Lavoie, Andrea, Uno, Kiyoko, Tuzcu, E. Murat, Nissen, Steven E.·2010·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2010.02.026

Open this paper in CoChat — free account Open PDF

Abstract

Objectives The aim of this study was to investigate the relationship between intravascular ultrasound (IVUS)-derived measures of atherosclerosis and cardiovascular outcomes.Background IVUS has been used in clinical trials to evaluate the effect of medical therapies on coronary atheroma progression.Methods Coronary plaque progression was evaluated in 4,137 patients in 6 clinical trials that used serial IVUS. The relationship between baseline and change in percent atheroma volume (PAV) and total atheroma volume with incident major adverse cardiovascular events (MACE) was investigated.Results PAV increased by 0.3% (p < 0.001), and 19.9% of subjects experienced MACE (0.9% death, 1.8% myocardial infarction, 18.9% coronary revascularization). Greater baseline PAVs were observed in patients who experienced myocardial infarctions (42.2 +/- 9.6% vs. 38.6 +/- 9.1%, p = 0.001), coronary revascularization (41.2 +/- 9.3% vs. 38.1 +/- 9.0%, p < 0.001), or MACE (41.3 +/- 9.2% vs. 38.0 +/- 9.0%, p < 0.001). Each standard deviation increase in PAV was associated with a 1.32-fold (95% confidence interval: 1.22 to 1.42; p < 0.001) greater likelihood of experiencing a MACE. During follow-up (21.1 +/- 3.7 months), greater increases in PAV, but not total atheroma volume, were observed in subjects who experienced MACE compared with those who did not (0.95 +/- 0.19% vs. 0.46 +/- 0.16%, p < 0.001). Each standard deviation increase in PAV was associated with a 1.20-fold (95% confidence interval: 1.10 to 1.31; p < 0.001) greater risk for MACE. Multivariate analysis revealed that factors associated with MACE included baseline PAV (p < 0.0001), change in PAV (p = 0.002), smoking (p = 0.0002) and hypertension (p = 0.01).Conclusions A direct relationship was observed between the burden of coronary atherosclerosis, its progression, and adverse cardiovascular events. The relationship between disease progression and outcomes largely reflected the need for coronary revascularization. These data support the use of atherosclerosis imaging with IVUS in the evaluation of novel antiatherosclerotic therapies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2010.02.026

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups
Detrano, R., Guerci, A. D., Carr, J. J., Bild, D. E., Burke, G., Folsom, A. R., Liu, K., Shea, S., Szklo, M., Bluemke, D. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa072100 · Cited by 2,989
Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis
Lorenz, M. W., Markus, H. S., Bots, M. L., Rosvall, M., & Sitzer, M. (2007) · Circulation · doi:10.1161/circulationaha.106.628875 · Cited by 2,977
Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis
Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Brown, B. G., Ganz, P., Vogel, R. A., Crowe, T., Howard, G., Cooper, C. J., Brodie, B. R., et al. (2004) · JAMA · doi:10.1001/jama.291.9.1071 · Cited by 2,361
Self-citation
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial
Nissen, S. E., Nicholls, S. J., Sipahi, I., Libby, P., Raichlen, J. S., Ballantyne, C. M., Davignon, J., Erbel, R., Fruchart, J. C., Tardif, J.-C., et al. (2006) · JAMA · doi:10.1001/jama.295.13.jpc60002 · Cited by 2,047
Self-citation
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
Brown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011090 · Cited by 1,979
Coronary Artery Calcium Score Combined With Framingham Score for Risk Prediction in Asymptomatic Individuals
Greenland, P. (2004) · JAMA · doi:10.1001/jama.291.2.210 · Cited by 1,825
Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes: A Randomized Controlled Trial
Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2292 · Cited by 1,707
Self-citation
Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure
Nissen, S. E., Tuzcu, E. M., Libby, P., Thompson, P. D., Ghali, M. G. H., Garza, D., Berman, L., Shi, H. H., Buebendorf, E., Topol, E. J., et al. (2004) · JAMA · doi:10.1001/jama.292.18.2217 · Cited by 1,147
Self-citation

Flagged first, then by citations

Show all 29 references

Sorted by citations

Items 301–400 of 473

Is atherosclerosis imaging the most sensitive way to assess patients' risk and the best way to conduct future drug trials? A pros-and-cons debate
Nanchen, D., & Raggi, P. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.08.024 · Cited by 6
Imaging of atherosclerotic plaques in obesity: excessive fat accumulation, plaque progression and vulnerability
Kataoka, Y., & Nicholls, S. J. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.975210 · Cited by 6
Self-citation
Predicting the Vulnerable Patient Using Intravascular Imaging ∗
Mintz, G. S. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.555 · Cited by 6
AI-Driven Quantitative Coronary CT Angiography in Suspected Coronary Artery Disease
van Rosendael, A. R., Nakanishi, R., Bax, J. J., Pontone, G., Mushtaq, S., Buechel, R. R., Gräni, C., Feuchtner, G. M., Lacaita, P. G., Patel, A. R., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102618 · Cited by 5
Suboptimal Control of Small Dense Low‐Density Lipoprotein Cholesterol Is Associated With Coronary Plaque Progression: An Intravascular Ultrasound Study
Amuti, A., Li, Y. R., Yuan, H., Feng, S., Tay, G. P., Tang, S. Y., Wu, X. R., Tao, L. Y., Lu, L., Zhang, R., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.038580 · Cited by 5
Multimorbidity increases risk of cardiovascular outcomes in permanent atrial fibrillation: Data from the RACE II study
van Deutekom, C., Velt, M. J. H., Gelder, I. C. V., Rienstra, M., & Mulder, B. A. (2025) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101686 · Cited by 5
Intravascular Ultrasound Imaging-Guided Percutaneous Coronary Intervention: Evidence and Practical Implications
Khan, S. U., Kleiman, N. S., & Shah, A. R. (2025) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1611 · Cited by 5
Cardiac CT Imaging of Plaque Vulnerability: Hype or Hope?
Willemink, M. J., Leiner, T., & Maurovich‐Horvat, P. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0714-0 · Cited by 5
Ischemic Cardiomyopathy: Contemporary Clinical Management
Alkar, B. S., Mattsson, G., & Magnusson, P. (2018) · InTech eBooks · doi:10.5772/intechopen.76723 · Cited by 5
C-reactive protein levels and plaque regression with evolocumab: Insights from GLAGOV
Nelson, A. J., Puri, R., Brennan, D. M., Anderson, T. J., Cho, L., Ballantyne, C. M., Kastelein, J. J. P., Köenig, W., Kassahun, H., Somaratne, R. M., et al. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100091 · Cited by 5
Self-citation
Association between major adverse cardiovascular events and pentraxin-3 in patients who have undergone coronary computed tomography angiography: from the FU-CCTA registry
Ohnishi, N., Shiga, Y., Tashiro, K., Kawahira, Y., Shibata, Y., Inoue, H., Morii, J., Nishikawa, H., Kato, Y., Kuwano, T., et al. (2022) · Heart and Vessels · doi:10.1007/s00380-022-02171-3 · Cited by 5
Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS
Puri, R., Nissen, S. E., Menon, V., Shao, M., Hsu, A., Bakris, G. L., Kastelein, J. J. P., Williams, B., Armbrecht, J., Brunel, P., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.019 · Cited by 5
Self-citation
Increased Carotid and Brachial Intima–Media Thickness is Related to Diffuse Coronary Involvement Rather Than Focal Lesions
Çanğa, A., Kocaman, S. A., Durakoğlugil, M. E., Çetın, M., Erdoğan, T., Çiçek, Y., & Şatıroğlu, Ö. (2012) · Angiology · doi:10.1177/0003319712445373 · Cited by 5
Update in Therapeutic Approaches to Plaque Stabilization
Nicholls, S. J., & Kataoka, Y. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0392-y · Cited by 5
Self-citation
A review in enormity of OCT and its enduring understanding of vulnerable plaque in coronary bifurcation lesion
Shrestha, R., Shrestha, A., Kan, J., & Chen, S. (2018) · International journal of cardiac imaging · doi:10.1007/s10554-018-1384-3 · Cited by 5
Emerging Role of Coronary Computed Tomography Angiography in Lipid-Lowering Therapy: a Bridge to Image-Guided Personalized Medicine
Miyoshi, T., Osawa, K., Ichikawa, K., Suruga, K., Miki, T., Yoshida, M., Nakagawa, K., Toda, H., Nakamura, K., Morita, H., et al. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1170-4 · Cited by 5
Multimodality imaging for the prevention of cardiovascular events: Coronary artery calcium and beyond
Koçyiğit, D., Scanameo, A., & Xu, B. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-19-654 · Cited by 5
Human vs. machine vs. core lab for the assessment of coronary atherosclerosis with lumen and vessel contour segmentation with intravascular ultrasound
Bass, R. D., García‐García, H. M., Sanz‐Sánchez, J., Ziemer, P. G. P., Bulant, C. A., Kuku, K. O., Kahsay, Y. A., Beyene, S., Melaku, G. D., Otsuka, T., et al. (2022) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-022-02563-6 · Cited by 5
Prediction of carotid plaque by blood biochemical indices and related factors based on Fisher discriminant analysis
Hu, J., Su, F., Ren, X., Cao, L., Zhou, Y., Fu, Y., Tatenda, G., Jiang, M., Wu, H., & Wen, Y. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02806-3 · Cited by 5
Intravascular Ultrasound in Vulnerable Plaque and Acute Coronary Syndrome
Okada, K., & Hibi, K. (2023) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2022.10.003 · Cited by 5
Effect of Alirocumab and Rosuvastatin or Rosuvastatin Alone on Lipid Core Plaque in Coronary Artery Disease Seen on Near-Infrared Spectroscopy Intravascular Ultrasound (ANTARES)
Otake, H., Tanimura, K., Sugizaki, Y., Toba, T., Kawamori, H., Shinke, T., & Hirata, K. (2019) · Circulation Reports · doi:10.1253/circrep.cj-18-0021 · Cited by 5
Intra-coronary Imaging for the Evaluation of Plaque Modifications Induced by Drug Therapies for Secondary Prevention
Kılıç, İ. D., Fabris, E., Kedhi, E., Ghilencea, L.-N., Caiazzo, G., Sherif, S. A., & Mario, C. D. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00890-4 · Cited by 5
Insufficient recovery of fractional flow reserve even after optimal implantation of drug-eluting stents: 3-year outcomes from the FUJI study
Hokama, Y., Tanaka, N., Takashima, H., Kadota, K., Fujita, H., Tan, M., Yamada, R., Naruse, H., Kawamura, A., Suzuki, N., et al. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.12.001 · Cited by 5
Comparing Coronary Atheroma Progression Rates and Coronary Events in the United States, Canada, Latin America, and Europe
Puri, R., Nicholls, S. J., John, J. S., Tuzcu, E. M., Kapadia, S. R., Uno, K., Kataoka, Y., Wolski, K., & Nissen, S. E. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.08.036 · Cited by 5
Self-citation
Coronary Artery Disease: from Atherosclerosis to Cardiogenic Shock
Cheng, J. M. (2015) · RePub (Erasmus University Rotterdam) · Cited by 5
Achieving LDL-C <1.0 mmol/L and cardiovascular outcomes in patients with coronary artery disease who received percutaneous coronary intervention
Kataoka, Y., Nicholls, S. J., Kitahara, S., Katasako-Yabumoto, A., Hosoda, H., Funabashi, S., Mitsui, K., Murai, K., Iwai, T., Sawada, K., et al. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120684 · Cited by 4
Self-citation
Cardiovascular event rate modifies response to pharmacologic LDL-C lowering in primary prevention: implications of a systematic review and meta-analysis for clinical practice
Karungi, I., Stevens, C. A. T., Brandts, J., & Ray, K. K. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101655 · Cited by 4
Total Coronary Artery Plaque Burden Measured by Cardiac Computed Tomography is Associated with Metabolic Syndrome
Konishi, M., Sugiyama, S., Sugamura, K., Nozaki, T., Ohba, K., Matsubara, J., Sumida, H., Nagayoshi, Y., Utsunomiya, D., Awai, K., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.8953 · Cited by 4
Eicosapentaenoic and docosahexaenoic acid supplementation and coronary artery calcium progression in patients with coronary artery disease: A secondary analysis of a randomized trial
Hariri, E. H., Asbeutah, A. A., Malik, A., Amangurbanova, M., Chedid, G., Daher, R., Hammoud, M. M. A., & Welty, F. K. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117388 · Cited by 4
Cumulative plaque burden analysis for phenotyping epicardial coronary artery disease
Tsai, T.-Y., Revaiah, P. C., Aldujeli, A., Miyashita, K., Tobe, A., Muramatsu, T., Kozuma, K., Kawashima, H., Ishibashi, Y., Nakazawa, G., et al. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133173 · Cited by 4
Stable coronary artery disease. Is it really stable? Lesion morphology interpretation by Grayscale and VH‐IVUS in patients with coronary artery disease
Brugaletta, S., Giacchi, G., Ortega‐Paz, L., García‐García, H. M., & Sabaté, M. (2016) · Continuing Cardiology Education · doi:10.1002/cce2.24 · Cited by 4
Intravascular ultrasound characteristics in patients with intermediate coronary lesions and borderline fractional flow reserve measurements
Yang, H., Lim, H., Seo, K., Choi, B., Choi, S., Yoon, M., Hwang, G., & Tahk, S. (2018) · Medicine · doi:10.1097/md.0000000000011901 · Cited by 4
Combining cholesterol-lowering strategies with imaging data: a visible benefit?
Köenig, W., Giovas, P. P., & Nicholls, S. J. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318798059 · Cited by 4
Self-citation
Achieving coronary plaque regression: a decades-long battle against coronary artery disease
Manubolu, V. S., & Budoff, M. J. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2069559 · Cited by 4
Association between Triglycerides to High-Density Lipoprotein Cholesterol Ratio and Death Risk in Diabetic Patients with New-Onset Acute Coronary Syndrome: A Retrospective Cohort Study in the Han Chinese Population
Shi, D., Wang, L., & Cong, H. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2306190 · Cited by 4
Utility of mass spectrometry for the diagnosis of the unstable coronary plaque
Jacob, S. S., Hassan, M. S., & Yacoub, M. H. (2015) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2015.25 · Cited by 4
Pigment epithelium-derived factor is associated with necrotic core progression during statin therapy
Nozue, T., Yamagishi, S., Hirano, T., Yamamoto, S., Tohyama, S., Fukui, K., Umezawa, S., Onishi, Y., Kunishima, T., Hibi, K., et al. (2014) · Coronary Artery Disease · doi:10.1097/mca.0000000000000192 · Cited by 4
Imaging of Coronary Arteries Aid in Prevention of Atherosclerosis and Clinical Coronary Heart Disease
Kuller, L. H., & Edmundowicz, D. (2011) · The Open Epidemiology Journal · doi:10.2174/1874297101104010152 · Cited by 4
Radial artery intima-media thickness regresses after secondary prevention interventions in patients’ post-acute coronary syndrome and is associated with cardiac and kidney biomarkers
Adingupu, D. D., Westergren, H. U., Dahgam, S., Jönsson‐Rylander, A., Blomster, J., Albertsson, P., Ömerovic, E., Svedlund, S., & Gan, L. (2017) · Oncotarget · doi:10.18632/oncotarget.18511 · Cited by 4
Personalized Statin Therapy and Coronary Atherosclerotic Plaque Burden in Asymptomatic Low/Intermediate-Risk Individuals
Muniyappa, R., Noureldin, R., Abd‐Elmoniem, K. Z., Khouli, R. H. E., Matta, J. R., Hamimi, A., Ranganath, S., Hadigan, C. M., Nieman, L. K., & Gharib, A. M. (2018) · Cardiorenal Medicine · doi:10.1159/000487205 · Cited by 4
Beyond greyscale IVUS assessment of progression/regression: it should be simple, but it's not
Mintz, G. S. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jet291 · Cited by 4
Cellular and molecular imaging of coronary atherosclerosis: clinical applications
Jaffer, F. A., Dweck, M. R., Tearney, G. J., Libby, P., & Tawakol, A. A. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf804 · Cited by 3
Atherosclerotic Plaque Imaging
Lavín, B., Gebhardt, P., Phinikaridou, A., & Botnar, R. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-53001-7_8 · Cited by 3
Relationship between left main coronary artery plaque burden and nonleft main coronary atherosclerosis
Shimizu, T., Mintz, G. S., Bruyne, B. D., Farhat, N. Z., Inaba, S., Cao, Y., Marso, S. P., Weisz, G., Serruys, P. W. J. C., Stone, G. W., et al. (2018) · Coronary Artery Disease · doi:10.1097/mca.0000000000000640 · Cited by 3
Influence of Microalbuminuria on Long-Term Survival and Cardiovascular or Limb Events in Peripheral Arterial Disease
Nakashima, K., Kumakura, H., Funada, R., Matsuo, Y., Sakata, K., Ichikawa, A., Iwasaki, T., & Ichikawa, S. (2021) · Annals of Vascular Diseases · doi:10.3400/avd.oa.21-00045 · Cited by 3
French expert group proposal for lipid-lowering therapy in the first 3 months after acute myocardial infarction
Schiele, F., Sabouret, P. F., Puymirat, É., ABDENNBI, K., LEBEAU, F., MELTZ, M., Kownator, S., & Angoulvant, D. (2023) · Panminerva Medica · doi:10.23736/s0031-0808.22.04799-1 · Cited by 3
Coronary atherosclerotic plaque progression: contributing factors in statin-treated patients
Clark, D., Puri, R., & Nissen, S. E. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1833716 · Cited by 3
Self-citation
Plaque Characterization with Computed Tomography Angiography Based on a Diluted-contrast Injection Protocol
Nakao, Y., Yoshida, K., Inaba, S., Tanabe, Y., Kurata, A., Uetani, T., Kido, T., Inoue, K., Mochizuki, T., & Yamaguchi, O. (2021) · Internal Medicine · doi:10.2169/internalmedicine.6683-20 · Cited by 3
Association of the Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Ratio and Body Mass Index with Coronary Plaque Regression
Tani, S., Matsumoto, M., Nakamura, Y., Nagao, K., & Hirayama, A. (2012) · American Journal of Cardiovascular Drugs · doi:10.1007/bf03261836 · Cited by 3
Rosuvastatin prevents aortic arch plaque progression and improves prognosis in ischemic stroke patients
Kaneko, K., Saito, H., Sasaki, T., Sugawara, S., Akasaka, M., Kanaya, T., & Kubota, I. (2016) · Neurological Research · doi:10.1080/01616412.2016.1263174 · Cited by 3
Intravascular ultrasound
Nishi, T. (2017) · Journal of the Japanese Coronary Association · doi:10.7793/jcoron.23.003 · Cited by 3
Anatomic or functional testing in stable patients with suspected CAD: contemporary role of cardiac CT in the ISCHEMIA trial era
Rodríguez-Granillo, G. A., Nieman, K., Carrascosa, P., Campisi, R., & Ambrose, J. A. (2020) · International journal of cardiac imaging · doi:10.1007/s10554-020-01815-7 · Cited by 3
Comparison of coronary atherosclerotic plaque progression in East Asians and Caucasians by serial coronary computed tomographic angiography: A PARADIGM substudy
Zekry, S. B., Sreedharan, S., Han, D., Sellers, S., Ahmadi, A. A., Blanke, P., Hadamitzky, M., Kim, Y.-J., Conte, E., Andreini, D., et al. (2021) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2021.09.012 · Cited by 3
Effect of Intensified Multifactorial Treatments on Coronary Atherosclerosis in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus ― Rationale and Design of the Randomized IMPACT-DM Trial ―
Okada, K., Kikuchi, S., Maejima, N., Kawaura, N., Kodama, S., Nakayama, N., Saka, K., Kataoka, S., Suzuki, H., Ishikawa, H. T., et al. (2025) · Circulation Reports · doi:10.1253/circrep.cr-25-0021 · Cited by 2
Comparison of Atheroma Burden Changes Using Conventional vs. End-Diastolic Intravascular Ultrasound Segmentation ― Post Hoc Analysis of the PACMAN-AMI Study ―
Yap, N. A. L., Bourantas, C. V., Losdat, S., Ng, N., Häner, J. D., Tanboga, I. H., Otsuka, T., Ueki, Y., Baumbach, A., Mathur, A., et al. (2026) · Circulation Journal · doi:10.1253/circj.cj-25-0590 · Cited by 2
Pathological mechanisms and research progress of multilevel intervention therapy for coronary heart disease
Tu, Z., Wei, Y., Liao, Y., Wan, Z., Zhou, Z., & Guo, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1816199 · Cited by 2
Advances in Wearable Bioimaging
Chen, J., Yin, J., Liu, Y., Kulkarni, N., Saito, E., Saucedo, B. J., Young, M., & Chen, J. (2026) · Advanced Materials · doi:10.1002/adma.202522393 · Cited by 2
The Role of Aggressive Lipid Lowering Therapy for Coronary Artery Disease
Daida, H., Fukushima, Y., & Ohmura, H. (2019) · Juntendō Igaku/Juntendo igaku · doi:10.14789/jmj.2019.65.jmj18-ln05 · Cited by 2
Técnicas de imagen en aterosclerosis
Escobar, C., & de Isla, L. P. (2021) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.12.002 · Cited by 2
Atherosclerotic plaque stabilization and regression
Poredoš, P., Spirkoska, A., & Poredoš, P. (2025) · VASA · doi:10.1024/0301-1526/a001202 · Cited by 2
Utilizing intravascular ultrasound for optimizing patient selection in venous sinus stenting: A pilot study
Turpin, J., White, T. G., Golub, D., Mehta, S. H., Werner, C., Donnelly, B. M., Toscano, D. T., Ferreira, C. C., Papadimitriou, K., Shah, K. A., et al. (2025) · Interventional Neuroradiology · doi:10.1177/15910199251355298 · Cited by 2
The use of intravascular ultrasound (IVUS) for direct portosystemic shunt (DIPS) evaluation
Krokidis, M. E., & Hatzidakis, A. A. (2011) · Interventional Medicine and Applied Science · doi:10.1556/imas.3.2011.4.7 · Cited by 2
Incremental value of carotid intraplaque hemorrhage for discriminating prior coronary events
Sun, J., Hippe, D. S., Underhill, H. R., Chu, B., Saam, T., Takaya, N., Cai, J., Oikawa-Wakayama, M., Yu, W., Dong, L., et al. (2015) · Neurovascular Imaging · doi:10.1186/s40809-015-0005-y · Cited by 2
Genetics paired with CT angiography in the setting of atherosclerosis
Li, D., & Budoff, M. J. (2016) · Clinical Imaging · doi:10.1016/j.clinimag.2016.04.005 · Cited by 2
Highlights of the Year in JACC 2010
DeMaria, A. N., Bax, J. J., Ben‐Yehuda, O., Feld, G. K., Greenberg, B., Hall, J. L., Hlatky, M. A., Lew, W. Y. W., Lima, J. A. C., Maisel, A. S., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.12.007 · Cited by 2
Self-citation
The Effect of FLT1 Variant on Long-Term Cardiovascular Outcomes: Validation of a Locus Identified in a Previous Genome-Wide Association Study
Lee, C. J., Lee, J., Oum, C.-Y., Youn, J., Kang, S., Choi, D., Jang, Y., Park, S., Jee, S. H., & Lee, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164705 · Cited by 2
Evaluation of human coronary vasodilator function predicts future coronary atheroma progression
Sidharta, S. L., Baillie, T. J., Howell, S. C., Nicholls, S. J., Montarello, N. L., Honda, S., Shishikura, D., Delacroix, S., Kim, S. W., Beltrame, J. F., et al. (2018) · Heart · doi:10.1136/heartjnl-2017-312579 · Cited by 2
Self-citation
Multimodality Imaging to Detect Vulnerable Plaque in Coronary Arteries and Its Clinical Application
Suwannasom, P., Sotomi, Y., Miyazaki, Y., Tenekecioğlu, E., Onuma, Y., & Serruys, P. W. J. C. (2018) · InTech eBooks · doi:10.5772/intechopen.70183 · Cited by 2
The PACMAN-AMI trial: game over for the “vulnerable plaque”?
Vergallo, R., & Patrono, C. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac222 · Cited by 2
Predicting the Future
Nicholls, S. J., & Puri, R. (2012) · Circulation · doi:10.1161/circulationaha.112.118059 · Cited by 2
Self-citation
Imaging of Pharmacologic Intervention
Marwick, T. H., & Narula, J. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.09.003 · Cited by 2
An amber signal lights up before the red: do not dismiss it
Mario, C. D., Mattesini, A., & Waksman, R. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx292 · Cited by 2
PCSK9 inhibition for patients with and without prior coronary revascularization: Potential additional benefit of a novel therapeutic agent
Navarese, E. P., & Raggi, P. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.07.038 · Cited by 2
High-Intensity Statin versus Upfront Equivalent-Dose Combination of Moderate-Intensity Statin with Ezetimibe Following Acute Myocardial Infarction (ROSUZET-AMI): protocol of a multicentre, open-label, randomised non-inferiority trial
Choo, E. H., Kim, C. J., Hwang, B., Lee, K. Y., Oh, G. C., Lim, S., Choi, I. J., Kim, D., Kwon, O. S., Lee, S., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-104127 · Cited by 1
Association between atherogenic index of plasma and rapid progression of coronary atherosclerosis in non-diabetic and diabetic adults: Insight from the PARADIGM study
Won, K. B., Lee, B. K., Hadamitzky, M., Kim, Y.-J., Sung, J. M., Conte, E., Pontone, G., Andreini, D., Budoff, M. J., Gottlieb, I., et al. (2026) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2026.03.011 · Cited by 1
The Effect of Eicosapentaenoic and Docosahexaenoic Acid Supplementation on Coronary Artery Calcium Progression in Subjects With Diabetes and Coronary Artery Disease: A Secondary Analysis of a Randomized Trial
Asbeutah, A. A., Daher, R., Malik, A., Hariri, E. H., Alfaddagh, A., Elajami, T. K., & Welty, F. K. (2024) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2024.06.001 · Cited by 1
Whole heart atherosclerosis volume and risk for major adverse cardiovascular events across the clinical likelihood for obstructive CAD; the CONFIRM2 study
van Rosendael, A. R., Nakanishi, R., Bax, J. J., Pontone, G., Mushtaq, S., Buechel, R. R., Gräni, C., Feuchtner, G. M., Lacaita, P. G., Patel, A. R., et al. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101712 · Cited by 1
Another Telescope for Examining Statins: the SATURN Trial
Patel, R., & CHILTON, R. J. (2012) · Clinical Diabetes · doi:10.2337/diaclin.30.3.115 · Cited by 1
Rust in the pipes: The importance of oxidative stress in the pathophysiology of coronary artery disease and the valuable contribution of translational research
Ragosta, M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.110 · Cited by 1
Relationships between inflammatory mediators and coronary plaque composition in patients with stable angina investigated by ultrasound radiofrequency data analysis
Satoh, S., Mori, E., Takenaka, K., Mori, T., Inoue, H., Numaguchi, K., & Hiyamuta, K. (2011) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-011-0058-z · Cited by 1
Avaliação ultrassonográfica intracoronária da carga aterosclerótica no tronco da artéria coronária esquerda prediz a extensão da doença no restante da árvore coronária: análise piloto
Falcão, B. D. A. A., Morais, G. R., Falcão, J. L. D. A. A., Cavalcante, R., Ribeiro, E. E., Martinez, E. E., & Lemos, P. A. (2011) · Revista Brasileira de Cardiologia Invasiva · doi:10.1590/s2179-83972011000300013 · Cited by 1
Imaging coronary atherosclerosis: is there space for magnetic resonance imaging?
Andrews, J., & Nicholls, S. J. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.13.22 · Cited by 1
Self-citation
Haptoglobin polymorphism in relation to coronary plaque characteristics on radiofrequency intravascular ultrasound and near-infrared spectroscopy in patients with coronary artery disease
Buljubasic, N., Oemrawsingh, R. M., Smeets, M. B., Cheng, J. M., Regar, E. S., van Geuns, R., Serruys, P. W. J. C., Boersma, E. H., Akkerhuis, K. M., Kardys, I., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.126 · Cited by 1
The Regression of Atherosclerosis: The Power of Multimodality Imaging
Feig, J. E. (2015) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.1000369 · Cited by 1
Disparities among Black and White patients in plaque burden and composition and long-term impact
Torguson, R., Mintz, G. S., Mario, C. D., ten Cate, T., Ali, Z. A., Singh, V., Skinner, W. H., Zhang, C., Shea, C., Kuku, K. O., et al. (2023) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2023.04.023 · Cited by 1
Impact of Cholesterol Variability as a Potential Residual Cardiovascular Risk Factor in the Elderly: Large Multicenter Common Data Model Database Analysis
Yum, Y., Koh, S. M., Park, S., Joo, H. J., Kim, Y., & Kim, E. J. (2023) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2024.4.e2 · Cited by 1
The relationship between glycemic risk and longitudinal changes in total physiological atherosclerotic burden in patients with coronary artery disease
Chu, J., Lai, Y., Yao, Y., Ye, W., Yao, T., Lin, H., Yuan, D., Ping, F., Zhu, G., Ding, H., et al. (2024) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-23-1160 · Cited by 1
Echocardiographic Imaging in Adult Congenital Heart Disease
Detterich, J. A., Yoon, A., & Chang, P. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8875-0_6 · Cited by 1
Left main coronary arterial endothelial function and heterogenous segmental epicardial vasomotor reactivity in vivo: novel insights with intravascular ultrasonography
Puri, R., Nicholls, S. J., Brennan, D. M., Andrews, J., King, K. L., Liew, G. Y. H., Carbone, A., Copus, B., Nelson, A. J., Kapadia, S. R., et al. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu133 · Cited by 1
Self-citation
Angina due to Obstructive Atherosclerotic Coronary Artery Disease: Diagnosis and Patient Risk Stratification
Kaski, J. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-41180-4_3 · Cited by 1
Impact of plaque characteristics on the degree of functional stenosis
Gonçalves, P. D. A., Hideo‐Kajita, A., & García‐García, H. M. (2017) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2017.04.09 · Cited by 1
Effects of intensive LDL lowering on coronary atherosclerosis
Zanchin, T., Koskinas, K. C., & Räber, L. (2017) · Cardiovascular Medicine · doi:10.4414/cvm.2017.00518 · Cited by 1
Residual Risk and Biology of the Disease: Implications for Plaque Imaging
Kataoka, Y., & Nicholls, S. J. (2014) · Contemporary cardiology · doi:10.1007/978-1-4939-0572-0_1 · Cited by 1
Self-citation
Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI
Giral, P., Hansel, B., & Chapman, J. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.105 · Cited by 1
Evolocumab Added to Statins to Reduce Progression of Coronary Atherosclerosis—Reply
Nicholls, S. J., Somaratne, R. M., & Nissen, S. E. (2017) · JAMA · doi:10.1001/jama.2017.3449 · Cited by 1
Self-citation
Following the Dynamic Changes of Coronary Atherosclerosis: An Uphill Battle
Chamié, D., & Pfau, S. E. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.037395 · Cited by 1
Cost-Effectiveness Matters! FFR Versus IVUS-Guided PCI in Modern Clinical Practice: Insights From the FLAVOUR Trial
Kim, S. O., Park, J., & Kim, U. (2024) · Korean Circulation Journal · doi:10.4070/kcj.2024.0327 · Cited by 1
Progression und Regression atherosklerotischer Plaques
Erbel, R. M. (2015) · Herz · doi:10.1007/s00059-015-4339-7
Intravascular Ultrasound Analysis to Determine the Relationship between High‐Density Lipoprotein Cholesterol and Lesion Characteristics in Patients with Coronary Artery Disease
Kitabata, H., Loh, J. P.-Y., PENDYALA, L. K., Omar, A., Magalhães, M. A., Torguson, R., Chen, F., Pichard, A. D., Brewer, H. B., & Waksman, R. (2014) · Journal of Interventional Cardiology · doi:10.1111/joic.12100
Plaque Regression and Stability Evaluated by Intravascular Ultrasound and Coronary Angioscopy: A Review
Saito, S., Hiro, T., Takayama, T., & Hirayam, A. (2012) · InTech eBooks · doi:10.5772/22361

Authors: Nicholls, S. J., Hsu, A., Wolski, K., Hu, B., Bayturan, O., Lavoie, A., Uno, K., Tuzcu, E. M., & Nissen, S. E.
Affiliations: Cleveland Clinic (US)
Corresponding author: Nicholls, Stephen J.
ORCID: Nicholls, Stephen J.
Wolski, Kathy
Hu, Bo
Lavoie, Andrea
Tuzcu, E. Murat
Nissen, Steven E.
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2010-05
Volume: 55
Issue: 21
Pages: 2399-2407
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2010.02.026
OpenAlex: W2054455620
Cited by: 475
References: 29
Citations by year: 2026: 20 · 2025: 15 · 2024: 15 · 2023: 25 · 2022: 31 · 2021: 22 · 2020: 24 · 2019: 33 · 2018: 35 · 2017: 32 · 2016: 52 · 2015: 40 · 2014: 41 · 2013: 29 · 2012: 24
FWCI: 30.17
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1172 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Institutional Repositories DataBase (IRDB) (submittedVersion)
Funders: Daiichi-Sankyo
Roche
Novo Nordisk
Takeda Pharmaceutical Company
Pfizer
AstraZeneca
Anthera
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cerebrovascular and Carotid Artery Diseases
Keywords: intravascular ultrasound, coronary artery disease, atheroma volume, plaque burden, major adverse cardiovascular events, myocardial infarction, coronary revascularization, plaque progression, cardiovascular risk prediction, smoking, coronary artery stenosis, coronary thrombosis
MeSH terms: Aged, Cardiovascular Diseases, Coronary Artery Disease, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Myocardial Revascularization, Probability, Severity of Illness Index, Cohort Studies, Multivariate Analysis, Confidence Intervals, Logistic Models, Survival Analysis, Treatment Outcome, Ultrasonography, Interventional, Disease Progression, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Intravascular Ultrasound-Derived Measures of Coronary Atherosclerotic Plaque Burden and Clinical Outcome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks